Terms: = Endocrine gland cancer AND ATRX, P46100, ZNF-HX, XNP, XH2, SHS, SFM1, RAD54, MRXHF1, MGC2094, ATR2, 546 AND Staging
16 results:
1. A Clinicopathological Analysis of Asian Patients with Adrenocortical Carcinoma: A Single-Center Experience.
Tsai WH; Dai SH; Lee CC; Chien MN; Zeng YH
Curr Oncol; 2023 Apr; 30(4):4117-4125. PubMed ID: 37185426
[TBL] [Abstract] [Full Text] [Related]
2. Comparison of nomogram for Primary Nonfunctional Pancreatic Neuroendocrine Tumors based on the 7th vs 8th edition of the AJCC cancer staging manual.
Heng X; Chen B; Zhao K; Li J; Wu W; Peng Y; Zhong R
PLoS One; 2023; 18(4):e0284930. PubMed ID: 37093837
[TBL] [Abstract] [Full Text] [Related]
3. Somatostatin receptor activity assessed by
Mapelli P; Bezzi C; Muffatti F; Ghezzo S; Baldassi F; Schiavo Lena M; Andreasi V; Canevari C; Magnani P; De Cobelli F; Gianolli L; Partelli S; Falconi M; Picchio M
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2818-2829. PubMed ID: 37010579
[TBL] [Abstract] [Full Text] [Related]
4. Robotic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: Analysis of surgical outcomes and long-term prognosis in a high-volume center.
Zhang XP; Xu S; Zhao ZM; Liu Q; Zhao GD; Hu MG; Tan XL; Liu R
Hepatobiliary Pancreat Dis Int; 2023 Apr; 22(2):140-146. PubMed ID: 36171169
[TBL] [Abstract] [Full Text] [Related]
5. Accurate Nodal staging in Pancreatic cancer in the Era of Neoadjuvant Therapy.
Javed AA; Ding D; Baig E; Wright MJ; Teinor JA; Mansoor D; Thompson E; Hruban RH; Narang A; Burns WR; Burkhart RA; Lafaro K; Weiss MJ; Cameron JL; Wolfgang CL; He J
World J Surg; 2022 Mar; 46(3):667-677. PubMed ID: 34994834
[TBL] [Abstract] [Full Text] [Related]
6. Pre-operative radiomics model for prognostication in resectable pancreatic adenocarcinoma with external validation.
Healy GM; Salinas-Miranda E; Jain R; Dong X; Deniffel D; Borgida A; Hosni A; Ryan DT; Njeze N; McGuire A; Conlon KC; Dodd JD; Ryan ER; Grant RC; Gallinger S; Haider MA
Eur Radiol; 2022 Apr; 32(4):2492-2505. PubMed ID: 34757450
[TBL] [Abstract] [Full Text] [Related]
7. Clinical utility of the AJCC 8
Badia RR; Woldu S; Patel HD; Singla N; Srivastava A; Cheaib JG; Pierorazio PM; Bagrodia A
Urol Oncol; 2021 Feb; 39(2):136.e19-136.e25. PubMed ID: 33353868
[TBL] [Abstract] [Full Text] [Related]
8. Molecular profile of pancreatic neuroendocrine neoplasms (PanNENs): Opportunities for personalized therapies.
Arakelyan J; Zohrabyan D; Philip PA
Cancer; 2021 Feb; 127(3):345-353. PubMed ID: 33270905
[TBL] [Abstract] [Full Text] [Related]
9. A comprehensive validation of the novel 8th edition of American Joint Committee on cancer staging manual for the long-term survivals of patients with non-functional pancreatic neuroendocrine neoplasms.
Yang M; Zeng L; Yao WQ; Ke NW; Tan CL; Tian BL; Liu XB; Xiang B; Zhang Y
Medicine (Baltimore); 2020 Nov; 99(46):e22291. PubMed ID: 33181635
[TBL] [Abstract] [Full Text] [Related]
10. Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials.
Vergote I; Coens C; Nankivell M; Kristensen GB; Parmar MKB; Ehlen T; Jayson GC; Johnson N; Swart AM; Verheijen R; McCluggage WG; Perren T; Panici PB; Kenter G; Casado A; Mendiola C; Stuart G; Reed NS; Kehoe S; ;
Lancet Oncol; 2018 Dec; 19(12):1680-1687. PubMed ID: 30413383
[TBL] [Abstract] [Full Text] [Related]
11. Loss of Chromatin-Remodeling Proteins and/or CDKN2A Associates With Metastasis of Pancreatic Neuroendocrine Tumors and Reduced Patient Survival Times.
Roy S; LaFramboise WA; Liu TC; Cao D; Luvison A; Miller C; Lyons MA; O'Sullivan RJ; Zureikat AH; Hogg ME; Tsung A; Lee KK; Bahary N; Brand RE; Chennat JS; Fasanella KE; McGrath K; Nikiforova MN; Papachristou GI; Slivka A; Zeh HJ; Singhi AD
Gastroenterology; 2018 Jun; 154(8):2060-2063.e8. PubMed ID: 29486199
[TBL] [Abstract] [Full Text] [Related]
12. Neuroendocrine tumors of the pancreas: current concepts and controversies.
Reid MD; Balci S; Saka B; Adsay NV
Endocr Pathol; 2014 Mar; 25(1):65-79. PubMed ID: 24430597
[TBL] [Abstract] [Full Text] [Related]
13. [Expression and significance of p-AKT, p-GSK3β and β-catenin in epithelial carcinoma of ovary].
Wei X; Lü QJ; Sun HX; Qi YF; Wang JO; Cao CC
Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):86-90. PubMed ID: 22455883
[TBL] [Abstract] [Full Text] [Related]
14. Screening for pancreatic cancer in a high-risk population with serum CA 19-9 and targeted EUS: a feasibility study.
Zubarik R; Gordon SR; Lidofsky SD; Anderson SR; Pipas JM; Badger G; Ganguly E; Vecchio J
Gastrointest Endosc; 2011 Jul; 74(1):87-95. PubMed ID: 21704809
[TBL] [Abstract] [Full Text] [Related]
15. [Evolution of therapeutic practices and survival of ovarian cancer in Bourgandi between 1982-1996: a registry-based study].
Benoit L; Désir JP; Fraisse J; Arnould L; Cuisenier J
Ann Chir; 2004 Oct; 129(8):415-21. PubMed ID: 15388369
[TBL] [Abstract] [Full Text] [Related]
16. The value of CT scanning and percutaneous fine needle aspiration of adrenal masses in biopsy-proven lung cancer.
Gillams A; Roberts CM; Shaw P; Spiro SG; Goldstraw P
Clin Radiol; 1992 Jul; 46(1):18-22. PubMed ID: 1643776
[TBL] [Abstract] [Full Text] [Related]
